Human sirtuin (SIRT) 1 and SIRT2, which possess nicotinamide adenosine dinucleotide (NAD + )-dependent deacetylase activity, exhibit anti-inflammatory actions. However, there are no data available on SIRT1 and SIRT2 expression and regulation in human intrauterine tissues. Thus, the aim of this study was to characterize the localization and expression of SIRT1 and SIRT2 in 1) placenta and fetal membranes before and after term spontaneous labor onset, 2) prelabor fetal membranes from the supracervical site (SCS) and a distal site (DS), and 3) in response to proinflammatory stimuli. Further, the effect of SIRT activation using resveratrol and SRT1720 on prolabor mediators was also assessed. SIRT1 and SIRT2 were localized in the syncytiotrophoblast layer and the cytotrophoblasts of the placenta, amnion epithelium, trophoblast layer of the chorion, and decidual cells. Additionally, SIRT2 was found within the endothelial walls of placental vessels. SIRT2, but not SIRT1, staining was significantly lower in amnion and chorion obtained from the SCS compared to a DS. On the other hand, SIRT1, but not SIRT2, gene and/or protein expression was significantly lower in placenta, amnion, and chorion obtained after labor compared to prelabor. SIRT1 expression, but not SIRT2, was down-regulated by lipopolysaccharide (LPS) and proinflammatory cytokines TNF and IL1B. The SIRT1 activators resveratrol and SRT1720 significantly decreased LPS-induced TNF, IL6, and IL8 gene expression and release and PTGS2 mRNA expression and resultant prostaglandin (PG) E 2 and PGF 2a release from human gestational tissues. In conclusion, SIRT1 possesses anti-inflammatory actions and thus may play a role in regulating pregnancy and parturition.
INTRODUCTION
Mammals possess seven sirtuins (SIRT1-7), which differ in their subcellular localization, tissue distribution, and protein substrates [1] . They are classed according to their sequence of amino acids: class 1 (SIRT1-3), class II (SIRT4), class III (SIRT5) and class IV (SIRT6 and 7). SIRTs possess either NAD þ -dependent histone deacetylase (SIRT1, 2, 3, and 5) or mono-ribosyltransferase (SIRT4 and 6) activity that contribute to cellular regulation (reaction to stressors, longevity). Where acetylation of core histones by histone acetyltransferases leads to unwinding of DNA, to subsequently allow transcription factors and RNA polymerase II to switch on gene transcription, deacetylation of core histones is generally associated with transcriptional repression [2, 3] . As such, SIRT1 and SIRT2, have been implicated as a key mediator in the resolution of inflammation [4] . They have also been implicated in aging, cell death/survival, metabolism, stress resistance and endocrine signaling [4] . Thus they may also play a role in human parturition, however, to date; there is little data available about the expression and regulation of SIRT proteins in human gestational tissues. However, the one study demonstrates an increase in SIRT1 in isolated amniotic epithelial cells in response to stretch [5] .
A successful outcome to labor and delivery at term is dependent on three processes: 1) fetal maturation consistent with extrauterine survival, 2) gestational and reproductive tract tissue remodeling (either by proteases that degrade extracellular matrix [ECM] or by apoptosis), and 3) the formation of uterotonic agents that promote synchronous myometrial contractions [6] [7] [8] [9] . Recent evidence from our own laboratory and others supports the involvement of upstream coordinating regulators capable of affecting the activity of the multiple terminal pathways involved in spontaneous onset labor and delivery [10] [11] [12] [13] [14] . For example, the nuclear transcription factors nuclear factor-jB (NFKB) and the nuclear hormone receptor peroxisome proliferator activator receptor (PPAR) appear to act in counterpoise to regulate the expression of the terminal effector pathways involved in labor and delivery: NFKB inducing expression while PPAR repressing expression. Recent evidence has shown that SIRT proteins negatively regulate the transcriptional activity of NFKB [15] [16] [17] [18] [19] [20] , whereas they positively regulate the transcriptional activity of PPAR [21] . Additionally, SIRT1 is a negative regulator of proinflammatory cytokines [18, 20] and matrix metalloproteinase (MMP) 9 expression [17] , which are required for processes of human labor [7] . As such, SIRTs are considered to have an anti-inflammatory function. As the processes of human labor exhibit all the hallmarks of an inflammatory response, SIRT proteins may play a role in this process. However, our knowledge concerning the expression, regulation, and functions of SIRT proteins in vivo during late pregnancy and at the time of labor is limited.
Thus, in this study, we use immunohistochemistry, Western blotting, and quantitative real-time PCR to determine the cellular distribution and gene and protein expression of SIRT1 and SIRT2 in human placenta, amnion, and choriodecidua from normal-term pregnancies. In order to ascertain whether SIRT proteins may play a role in the processes of human labor and delivery, the expression of SIRT1 and SIRT2 is also studied in placenta and fetal membranes before and after term spontaneous labor onset. Furthermore, we utilize the technique we have established for the identification of fetal membranes overlying the cervix (i.e., supracervical site [SCS] ) in prelabor, postdelivery tissues [22] [23] [24] to characterize the localization and expression of SIRT1 and SIRT2 proteins in SCS fetal membranes and compare them to distal fetal membranes in order to better understand the mechanisms that may be involved in rupture of fetal membranes. The regulation of proinflammatory cytokines and prostaglandins are investigated using two SIRT activators (SRT1720 and resveratrol).
MATERIALS AND METHODS

Sample Collection
The Research Ethics Committee of Mercy Health approved this study. Written, informed consent was obtained from participating women. The clinical summary of patients used in this study is summarized in Table 1 . There was no difference in maternal age and body mass index, parity, or gestational age of the patients recruited. Human placentae and attached fetal membranes were obtained from women who delivered healthy, singleton infants at term (!37 wk gestation) 1) before labor undergoing elective Cesarean section (indications for Cesarean section were breech presentation and/or previous Cesarean section) and 2) after spontaneous labor and normal vaginal delivery (n ¼ 6-8 per group). For the prelabor samples, identification of the SCS was performed as we have previously detailed [22] [23] [24] . Briefly, prior to commencement of the Cesarean section, a swab soaked in Bonneys Blue dye (1:1 mixture of brilliant green [0.5% wt/vol] and crystal violet [0.5% wt/vol] dissolved in 90% ethanol vol/ vol) is introduced through the cervix onto the chorion lying above the internal os of the cervix. On delivery of the placenta, a blue mark is obvious on the membrane where the dye had been applied. Fetal membranes were collected from both the SCS and from a distal site (DS) with no Bonneys Blue staining (about 2 cm away from the periplacental edge). Postlabor fetal membranes were identified and sampled in accordance with techniques originally described by Malak and Bell [25] ; amnion and underlying choriodecidua were obtained from along the line of fetal membrane rupture. The placenta and fetal membranes were collected within 30 min of application of Bonneys Blue and transferred within 10 min of delivery to the laboratory in the hospital. A placental lobule was removed from the central region of the placenta. The basal plate and chorionic surface were removed from the placental tissue, and villous tissue was obtained from the middle cross section. Placental tissue was blunt dissected to remove visible connective tissue and calcium deposits. Tissue samples were 1) fixed and paraffin embedded for immunohistochemical analysis, 2) snap frozen in liquid nitrogen and stored at À808C for RNA and protein extraction, or 3) used immediately for explant and cell culture experiments.
Tissue Explant Culture
Placental tissue (prepared as detailed previously) was placed in DMEM at 378C in a humidified atmosphere of 8% O 2 and 5% CO 2 for 1 h. Tissues were blotted dry on sterile filter paper and transferred to 24-well tissue culture plates (100 mg wet weight/well). The explants were incubated, in duplicate, in 2 ml DMEM containing penicillin G (100 U/ml), streptomycin (100 lg/ml), and Lglutamine (2 mM). To determine the effect of proinflammatory mediators on SIRT expression, tissues were incubated in the presence of 10 lg/ml LPS, 20 ng/ml TNF, and 10 ng/ml IL1B. The chosen concentrations of LPS, TNF, and IL1B are based on previously published studies [26] . To determine the effect of SIRT activation on proinflammatory cytokines, tissues were incubation, in the absence or presence of 10 lg/ml LPS, with and without 1) 50, 100, and 200 lM resveratrol and 2) 10 and 20 lM SRT1720. After 6 and/or 24 h of incubation, tissues were collected and stored at À808C until assayed for 1) expression of nuclear RELA (NFKB p65) and cytoplasmic NFKBIA (IjB-a) proteins by Western blotting, 2) nuclear RELA activity by ELISA, and 3) mRNA expression by quantitative real-time PCR as detailed here. Media were collected and stored at À808C until assayed cytokine and prostaglandin release by ELISA. Data were corrected for total protein and expressed as mean fold change compared to LPS.
Gene Silencing of SIRT1 with siRNA in Primary Amnion Cells
Primary amnion epithelial cultures were used to investigate the effect of resveratrol on siRNA-mediated gene silencing of SIRT1 on proinflammatory cytokine and prostaglandin gene expression. Cells were prepared as previously described [27] and incubated in DMEM/F12 enriched with 20% FCS, 10 ng/ml EGF, 2 mM L-glutamine, 100 U/ml penicillin G, and 100 lg/ml streptomycin. Primary amnion cells (passage 1) at 40%-50% confluence in six-well plates were transfected using TransIT-siQUEST reagent according to manufacturer guidelines (Mirus Bio, Madison, WI). Mock transfected cells (transfection reagent only) were used as the vehicle. Cells were transfected with 75 nM SIRT1 siRNA (Ambion, Austin, TX) in DMEM/F12 with 5% FCS for 48 h. The medium was then replaced with DMEM/F12 (with 1% FCS) containing 10 lg/ml LPS and 50 lM resveratrol, and the cells were incubated at 378C for 24 h. Cells and media were collected separately and stored at À808C.
Immunohistochemistry
Fetal membrane tissues were rolled up (with amnion innermost), and all rolls were placed in embedding cassettes (Techno-Plas, South Australia, Australia), fixed in buffered formaldehyde solution (4% vol/vol), and embedded in paraffin. Serial sections (4 lm thick) were cut and mounted on sections onto superfrost plus slides. Sections were deparaffinized followed by an antigen retrieval step (boiled in 10 mM Tris and 1 mM EDTA, pH 9.0, for 10 min followed by 20 min of incubation). Endogenous peroxidase activity was removed using 3% H 2 O 2 (vol/vol) in methanol for 10 min. Sections were transferred to tris-buffered saline (TBS; 20 mM Tris pH 7.6, 150 mM NaCl). The sections were incubated in a humidity chamber for 1 h in antibody diluted in 1% bovine serum albumin (BSA) in TBS (wt/vol). The primary antibodies, purchased from Sigma (St. Louis, MO, USA), were rabbit polyclonal anti-SIRT1 (S5322) and rabbit polyclonal anti-SIRT2 (S8447). Both SIRT1 and SIRT2 were used at 10 lg/ml in 1% BSA/TBS (wt/vol). After incubation, the binding sites were labeled with Dako Envisionþpolymer linked secondary reagent and visualized using Dako DABþ (Dakocytomation, Carpinteria, CA). Nuclei were counterstained with Mayers hematoxylin, and the sections were dehydrated and coverslipped using a resinous mounting agent. Positive controls, which were composite slides with tonsil, breast tumor, and ovarian tumor, were included in each run. Negative control slides, where primary antibody was replaced with normal rabbit IgG serum, were also included.
Sections were assessed microscopically for both intensity and extent of staining. The entire tissue section was scored, and the extent of staining was determined on a scale of 0-5 according to the estimated percentage of cells stained: 0 , 10%, 1 ¼ 11%-25%, 2 ¼ 26%-50%, 3 ¼ 51%-75%, 4 ¼ 76%-90%, and 5 . 90%. Staining intensity was assessed on a scale of 0-3: 0 ¼ no staining, negative; 1 ¼ pale brown, weak; 2 ¼ brown, moderate; and 3 ¼ dark brown, strong [28] .
Western Blotting
Assessment of SIRT1 and SIRT2 protein expression was analyzed by Western blotting. The primary antibodies, purchased from Sigma, were rabbit polyclonal anti-SIRT1 (S5322) and rabbit polyclonal anti-SIRT2 (S8447 cytoplasmic and nuclear protein was extracted as we have previously described [29] [30] [31] ). Assessment of NFKBIA protein expression was analyzed by Western blotting. Rabbit polyclonal anti-RELA (sc-372), rabbit polyclonal anti-NFKBIA, and horseradish peroxidase-conjugated goat anti-rabbit IgG were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Forty micrograms of protein were separated on either 10.5%-14% or 7.5% criterion polyacrylamide gels (Bio-Rad Laboratories, Hercules, CA) and transferred to polyvinylidine fluoride. Protein expression was identified by comparison with the mobility of protein standard. Membranes were viewed and analyzed using the Chemi-Doc system (Bio-Rad). Quantitative analysis of the relative density of the bands in Western blots was performed using Quantity One 4.2.1 image 
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analysis software (Bio-Rad). Data were corrected for background, standardized to b-actin, and expressed as optical density (OD)/mm 2 .
RNA Extraction and Quantitative Real-Time PCR
Total RNA was extracted from approximately 100 mg of tissue using Tri Reagent according to the manufacturer's instructions (Sigma-Aldrich). RNA concentrations were quantified using a spectrophotometer (Smart Spec; BioRad). RNA quality and integrity were determined via the A 260 /A 280 ratio. One microgram of RNA was converted to cDNA using iScript cDNA Synthesis Kit (Bio-Rad) according to the manufacturer's instructions. The cDNA was diluted 10-fold, and 2 ll of cDNA were used to perform RT-PCR using Sensimix Plus SYBR green (Quantace, Alexandria, New South Wales, Australia) and 100 nM of QuantiTect Primer Assays (Qiagen, Germantown, MD). The specificity of the product was assessed from melting curve analysis. RNA without reverse transcriptase during cDNA synthesis as well as PCR reactions using water instead of template showed no amplification. A positive control sample was also used in each run on each plate.
Following baseline correction, the fluorescence threshold level was set during the geometric (exponential) phase of PCR amplification to generate the threshold cycle (C T ) value for each amplification curve. Average gene C T values were normalized to the average actin C T values of the same cDNA sample. Variations in gene expression were calculated by the comparative C T method, which compares test samples to a calibrator sample. This method uses results obtained for a uniformly expressed control gene to correct for differences in the amount of RNA present in the two samples being compared in order to generate a DC T value. The following were used as the calibrators; placenta for Figure 2 , prelabor group for Figure 3 , SCS for Figure 5A , basal for Figure 6 , mock for Figure 8 , and LPS control for Figure 10C . Gene expression was determined using the 2
ÀDDCt method [32] .
Immunohistochemical localization of SIRT1 and SIRT2 in human placenta and fetal membranes. A) SIRT1 staining was contained in syncytiotrophoblasts. No staining was detected in the endothelial cells. B) SIRT1 is localized primarily to the trophoblasts of the chorion layer, amnion epithelium, and decidua. C) SIRT2 staining was contained mainly in the syncytiotrophoblasts, cytotrophoblasts, and the walls of the endothelial cells of the placental villi. D) Positive strong SIRT2 staining was found in the amniotic epithelium, the trophoblast layer of the chorion, and decidua. E) No specific staining for SIRT is seen in the negative control for placenta. F) No specific staining for SIRT is seen in the negative control for fetal membranes. Original magnification 3250 (A-D) and 3100 (insets in A-D, E, and F). sy, syncytiotrophoblast cells; cy, cytotrophoblast cells; ec, endothelial cells; ae, amnion epithelial layer; cl, connective tissue layer; ct, chorionic trophoblast layer; dec, decidua.
FIG. 2. Expression of SIRT1
(A) and SIRT2 (B) mRNA in term human placenta, amnion, and choriodecidua. Quantitative real-time PCR was performed on mRNA extracted from term placenta, amnion, and choriodecidua from women not in labor (n ¼ 6). RN18S1 mRNA expression was used for the normalization of the data. SIRT mRNA expression is displayed as mean fold change ratio (relative to placenta) as calculated by the 2 ÀDDCT method. Data are displayed as the mean 6 SEM. *P , 0.05 vs. placenta.
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Assessment of RELA DNA Binding Activity NFKB DNA binding in nuclear protein extracts was assessed using a commercially available RELA Transcription Factor ELISA according to manufacturer's instructions (TransAM; Active Motif, Carlsbad, CA) where TPA-stimulated Jurkat nuclear protein extract was used as a positive control for NFKB activation and specificity of NFKB binding was assessed using wildtype and mutated consensus oligonucleotides. A BioRad Benchmark Microplate Reader was used to read the sample absorbance, with data expressed as OD at 450 nm.
Statistical Analysis
Statistical analyses were performed using a commercially available statistical software package (Statgraphics Plus version 3.1; Statistical Graphics Corp., Rockville, MD). Two sample comparisons were analyzed by either a paired sample comparison or a Student t-test. For all other comparisons, analysis was performed using a one-way ANOVA (using the Tukey honestly significant differences correction to discriminate among the means); homogeneity of data was assessed by the Bartlett test, and, when significant, data were logarithmically transformed before further analysis. Statistical significance was ascribed to P ,0.05. Data were expressed as mean 6 SEM.
RESULTS
Expression and Localization of SIRT1 and SIRT2 In Human Gestational Tissues
Immunohistochemical localization of SIRT1 expression in term placenta and fetal membranes. Immunohistochemistry was used to determine the cellular localization of SIRT1 in human placenta and fetal membranes (amnion and choriodecidua). Placenta exhibited moderate SIRT1 staining, which was only cytoplasmic (Fig. 1A) . It was localized to the syncytio-
Effect of human term labor on SIRT1 (A) and SIRT2 (B) mRNA expression in placenta, amnion, and chorion. Quantitative real-time PCR was performed on mRNA extracted from term placenta, amnion, and chorion from women before labor (n ¼ 6) and after labor (n ¼ 6) at term. RN18S1 mRNA expression was used for the normalization of the data. SIRT mRNA expression is displayed as mean 2 ÀDDCT 6 SEM (n ¼ 6 per group). *P , 0.05 vs. prelabor SIRT mRNA expression.
FIG. 4. A)
Effect of human term labor on placental SIRT1 and SIRT2 protein expression. Western blotting was performed on protein extracted from term placenta from women before labor (n ¼ 8) and after labor (n ¼ 8) at term. Actin protein expression was used for the normalization of the data. All data are displayed as the mean optical density 6 SEM (n ¼ 8 per group). *P , 0.05 vs. prelabor SIRT protein expression. KD, kilodalton. B) Immunohistochemical expression of SIRT1 in term fetal membranes obtained before and after labor. Original magnification 3250, insert 3100. ae, amnion epithelial layer; cl, connective tissue layer; ct, chorionic trophoblast layer. 170 trophoblast layer with minimal staining in the cytotrophoblasts. There was little or no SIRT1 staining within the villous structure and no staining of the endothelium. Fetal membranes exhibited strong SIRT1 staining (Fig. 1B) . There was positive SIRT1 staining in the amnion epithelium, which was predominantly cytoplasmic. On the other hand, cytoplasmic and nuclear SIRT1 staining was detected in the trophoblast layer of the chorion. Decidua, where present, exhibited fairly weak but extensive SIRT1 staining that was both cytoplasmic and nuclear. There was also positive, mostly cytoplasmic SIRT1 staining of cells within the spongy layer of the fetal membranes.
Immunohistochemical localization of SIRT2 expression in term placenta and fetal membranes. Immunohistochemistry was used to determine the cellular localization of SIRT2 in human placenta and fetal membranes (amnion and choriodecidua). Placenta exhibited strong and extensive cytoplasmic and nuclear SIRT2 staining (Fig. 1C) . SIRT2 staining was localized in the syncytiotrophoblast layer, cytotrophoblasts, and the endothelial walls of placental vessels. There was also some staining of cells within the villi. Fetal membranes also exhibited very strong and extensive SIRT2 staining (Fig. 1D) . The amnion epithelium and the decidual cells showed evidence of both cytoplasmic and nuclear staining. Additionally, the fibroblasts in the spongy layer of the fetal membranes had cytoplasmic and nuclear SIRT2 staining. On the other hand, the trophoblast cells of the chorion exhibited predominantly cytoplasmic SIRT2 staining. There was also staining of cells within the spongy layer of the membranes for SIRT2. No staining was present in the negative controls for SIRT1 and SIRT2 in placenta (Fig. 1E ) and fetal membranes (Fig. 1F) .
SIRT1 and SIRT2 mRNA expression in term placenta and fetal membranes. SIRT1 and SIRT2 mRNA expression in human gestational tissues at term was analyzed using quantitative real-time PCR. RN18S1 (18S) mRNA was used for normalization of the data. SIRT1 and SIRT2 were detected in all placenta, amnion, and choriodecidua samples, with the data presented in Figure 2 . SIRT1 and SIRT2 mRNA expression was significantly higher in placenta compared to both amnion and choriodecidua. The gene expression of SIRT1 and SIRT2 was similar between amnion and choriodecidua (Fig. 2) .
Altered Expression of SIRT1 and SIRT2 in Association with Human Labor and Membrane Rupture
Effect of human labor and membrane rupture on SIRT1 and SIRT2 expression. Human placenta and fetal membranes 
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were collected from women at term 1) at cesarean section before the onset of labor (prelabor) and 2) after spontaneous labor and membrane rupture (postlabor). For the prelabor group, amnion and choriodecidua were obtained from the SCS. Postlabor amnion and choriodecidua were obtained from along the rupture line. SIRT1 and SIRT2 mRNA expression is demonstrated in Figure 3 . SIRT1 mRNA expression, but not SIRT2, was significantly lower after spontaneous labor in placenta and chorion. There was, however, no effect of labor on SIRT1 and SIRT2 mRNA expression for amnion.
For placenta, Western blotting was used to examine the protein expression of SIRT1 and SIRT2 before and after term labor (Fig. 4A) . SIRT1 protein expression, but not SIRT2, was significantly lower after spontaneous labor. For fetal membranes, immunohistochemistry was used to examine the intensity and extent of SIRT1 and SIRT2 protein expression in fetal membranes obtained from the prelabor SCS and postlabor site of rupture (SOR). A summary of the intensity and extent of staining is presented in Table 2 . When compared with prelabor supracervical fetal membranes, both intensity and 172 extent of SIRT1 staining were significantly lower in amnion and chorion obtained from the postlabor SOR (Fig. 4B ). There was, however, no difference in intensity and extent of SIRT2 staining between fetal membranes from prelabor SCS and postlabor SOR (data not shown).
Effect of supracervical apposition on SIRT1 and SIRT2 protein expression in prelabor fetal membranes. Quantitative real-time PCR was used to determine the effect of SC apposition on SIRT1 and SIRT2 mRNA expression in amnion (Fig. 5A ). There no difference in SIRT1 and SIRT2 mRNA expression between SC and distal amnion. Gene expression studies were not performed on chorion, as DS chorion has attached decidua [22, 24] . Immunohistochemistry was used to examine the intensity and extent of SIRT1 and SIRT2 protein FIG. 8. SIRT1 is involved in the anti-inflammatory effects of resveratrol. A) Efficiency of knockdown of SIRT1 mRNA in primary amnion cells using siRNA. After 48-h transfection with SIRT siRNA, human primary amnion cells were incubated with 50 lM resveratrol for 24 h in the presence of 10 lg/ml LPS (n ¼ 3 independent experiments). RNA was extracted and converted to cDNA and expression analyzed by quantitative real-time PCR as detailed in Materials and Methods. RN18S1 mRNA expression was used for the normalization of the data. Gene expression is displayed as mean fold change (compared to mock) 6 SEM (n ¼ 3 per group). *P , 0.05 vs. mock mRNA expression. B) Efficiency of knockdown of SIRT1 protein expression using siRNA. After 48-h transfection with SIRT siRNA, human primary amnion cells were incubated with 50 lM resveratrol for 24 h in the presence of 10 lg/ml LPS (n ¼ 3 independent experiments). Cell lysates were analyzed for SIRT1 and b-actin by Western blotting. Data are representative of n ¼ 4 experiments. C) Effect of resveratrol on prolabor mediator release. After 48-h transfection with SIRT1 siRNA, human primary amnion cells were incubated with 50 lM resveratrol for 24 h in the presence of 10 lg/ml LPS. Media were collected and assayed for the release of IL8, PGE 2 , and PGF 2a as detailed in Materials and Methods. Each bar represents the mean fold change (compared to mock transfected) 6 SEM. *P , 0.05 vs. mock transfected release. 
expression in prelabor fetal membranes from the SCS and a DS. A summary of the intensity and extent of staining is presented in Table 2 . There was no difference in both the intensity and the extent of staining of SIRT1 between SC and distal fetal membranes (data not shown). On the other hand, when compared to the DS, the intensity of SIRT2 staining was significantly lower in amnion and chorion obtained from the SCS (Fig. 5B) .
Effect of Prolabor Mediators on SIRT1 and SIRT2 Expression
Placenta was treated in the absence or presence of 10 lg/ml LPS, 20 ng/ml TNF, and 10 ng/ml IL1B for 24 h and the gene expression of SIRT1 and SIRT2 analyzed. The effect of proinflammatory mediators on SIRT1 and SIRT2 mRNA expression is depicted in Figure 6 . LPS, TNF, and IL1B all significantly decreased SIRT1 mRNA expression by approximately 50%, 28%, and 26%, respectively. There was, however, no effect of prolabor mediators on SIRT2 mRNA expression.
Regulation of Prolabor Mediators by SIRT1 Activators
The previously mentioned studies demonstrate that in human gestational tissues, SIRT1 is down-regulated with human labor and by proinflammatory mediators. The next aim was to determine if SIRT1 exerts anti-inflammatory effects in human gestational tissues. Thus, we used two activators of SIRT1: the natural polyphenol resveratrol and the synthetic compound SRT1720.
Effect of Resveratrol on Prolabor Mediators in Human Placenta and Fetal Membranes
To explore the effect of resveratrol on the inflammatory response in placenta, we examined the effect of increasing concentrations of resveratrol (50, 100, and 200 lM) on the expression and release of proinflammatory cytokines, prostaglandins, and proteases in human placenta and fetal membranes. In initial experiments, tissue explants were incubated in the presence of 10 lg/ml LPS for 6 h with 50, 100, and 200 lM resveratrol (n ¼ 6). Additional experiments were then performed over 1-and 24-h incubation periods with 200 lM resveratrol in the presence of 10 lg/ml LPS (n ¼ 4). It should be noted that these experiments were performed in both placenta villous tissue and fetal membranes. Similar results for placenta and fetal membranes were   FIG. 10 . SIRT1 exerts anti-inflammatory actions in human placenta. Human placenta was incubated with and without 10 and 20 lM SRT1720 in the absence or presence of 10 lg/ml LPS for 24 h. Incubation medium was assayed for the release of IL6 and IL8 (A) and PGE 2 and PGF 2a (B) . Each bar represents the mean fold change (compared to LPS control) 6 SEM (n ¼ 4). *P , 0.05 vs. LPS-stimulated release. C) RNA was extracted and converted to cDNA and expression analyzed by quantitative real-time PCR as detailed in Materials and Methods. RN18S1 mRNA expression was used for the normalization of the data. Gene expression is displayed as mean fold change (compared to LPS control) 6 SEM (n ¼ 3 per group). *P , 0.05 vs. LPS control mRNA expression. obtained, but for succinctness, only the data for placenta are shown here.
Proinflammatory Cytokines
Coincubation of human placenta with increasing concentrations of resveratrol over 6 h of incubation caused a dosedependent decrease in LPS-stimulated release of TNF (Fig.  7A) , IL6 (Fig. 7B) , and IL8 (Fig. 7C) . Similarly, 200 lM resveratrol treatment of placenta for 24 h significantly suppressed LPS-induced release of TNF (Fig. 7A), IL6 (Fig.  7B) , and IL8 (Fig. 7C) . Quantitative real-time PCR analysis was performed on RNA isolated from placenta stimulated with 10 lg/ml LPS with and without resveratrol ( Table 3) . Cotreatment with resveratrol for 24 h significantly suppressed LPS-induced IL6 and IL8 but not TNF gene expression in placenta.
Prostaglandins
Incubation of tissues with increasing concentrations of resveratrol for 6 h significantly diminished LPS-stimulated release of PGE 2 (Fig. 7D ) and PGF 2a (Fig. 7E) . Likewise, the addition of 200 lM resveratrol for 24 h suppressed LPSinduced release PGE 2 (Fig. 7D ) and PGF 2a (Fig. 7E ) from human placenta. The effect of resveratrol on the mRNA expression of the time-limiting enzyme involved in prostaglandin formation PTGS2 was performed by quantitative realtime PCR. Twenty-four hour resveratrol incubation significantly repressed LPS-stimulated PTGS2 mRNA expression (Table 3) .
Mechanisms by Which the Anti-Inflammatory Actions of Resveratrol in Human Gestational Tissues Are Elicited
In nongestational tissues, the actions of resveratrol are in part due to activation of SIRT1 [33] [34] [35] [36] [37] . In support of this, we show that resveratrol increases SIRT1 mRNA expression in human placenta (Table 3) . Having shown that resveratrol activates SIRT1, the next aim was to determine if the observed anti-inflammatory actions of resveratrol are mediated by SIRT1. To elucidate the cellular mechanism underlying the protective effects of resveratrol, the down-regulation of SIRT1 mRNA (Fig. 8A) and protein (Fig. 8B) expression was achieved by RNA interference in primary amnion cells. We found that the anti-inflammatory effects of resveratrol could be inhibited by knockdown of SIRT1. Specifically, when compared to mock transfected cells, resveratrol treatment was unable to inhibit release of IL8, PGE 2 , and PGF 2a by SIRT1-deficient primary amniotic cells (Fig. 8C) .
The observed anti-inflammatory effects of resveratrol have also been attributed to antagonizing the activity of NFKB [38] [39] [40] [41] [42] [43] [44] . Therefore, we aimed to determine if the observed antiinflammatory actions of resveratrol in human gestational tissues are also due to inhibiting the activity, protein and/or mRNA expression of these proteins in human placenta over 1-, 6-, and 24-h treatment. The binding ability of RELA to DNA consensus sequences was also measured using a commercially available kit. An NFKB wild-type consensus oligonucleotide was used to monitor the specificity of the assay. The wild-type oligonucleotide, by competing for NFKB binding to the probe immobilized on the plate, acted as an effective competitor for RELA binding (data not shown). Resveratrol, at all concentrations tested, had no effect on LPS-stimulated RELA DNA binding activity in nuclear extracts prepared from placenta after both 6-and 24-h treatments (Fig. 9) . Western blot and quantitative real-time PCR analysis also revealed that both 6-and 24-h resveratrol treatment had no effect on RELA mRNA and protein (data not shown) expression in human placenta. Furthermore, LPS-induced degradation of NFKBIA protein expression was unaffected by 1- (Fig. 9C ), 6-(data not shown), and 24-h (data not shown) and resveratrol treatment. Similar results were obtained for fetal membranes (data not shown).
Effect of SIRT1 Activator SRT1720 on Prolabor Mediators in Human Placenta
Placental villous tissue was treated with the SIRT1 activator SRT1720 (10 and 20 lM) in the absence or presence of LPS for 24 h, and the release of the proinflammatory cytokines IL6 and IL8 and the prostaglandins PGE 2 and PGF 2a were assayed. Placenta were incubated in the presence of LPS, as it is likely to be a factor stimulating the production of cytokines, prostaglandins, and proteases in the context of infection mediated preterm labor. There was no effect of SRT1720 on basal cytokine and prostaglandin release (data not shown). On the other hand, SRT1720 significantly decreased LPS-induced cytokine release (Fig. 10A ) and mRNA expression (Fig. 10C) . Furthermore, SRT1720 attenuated LPS-induced PTGS2 mRNA expression (Fig. 10C ) and resultant PGE 2 and PGF 2a release (Fig. 10B) . The specificity of SRT1720 was demonstrated by significantly increased SIRT1 mRNA expression after SRT1720 treatment (Fig. 10C) .
DISCUSSION
In this study, we report the localization and expression of SIRT1 and SIRT2 in term placenta and fetal membranes. Lower mRNA and/or protein expression of SIRT1 was found in placenta, amnion, and choriodecidua obtained from women after labor. On the other hand, prelabor fetal membranes overlying the cervix were associated with less SIRT2 when compared to distal fetal membranes. SIRT1 expression is down-regulated by LPS and proinflammatory cytokines. The natural polyphenol resveratrol inhibits cytokine and prostaglandin release via SIRT1 activation. Likewise, the SIRT1 activator SRT1720 down-regulates proinflammatory cytokines and prostaglandin expression and release from human placenta. Collectively, these data suggest that SIRT1 is anti-inflammatory in human gestational tissues.
The dynamics of membrane rupture are multifactorial and complex, and the mechanisms of rupture are not completely elucidated. However, it is clear that more than one biological process leads to weakening and subsequent rupture of the fetal membranes. The exact sequences of events are yet to be fully determined; however, both biochemical and physical events 
SIRT1 REGULATES KEY PATHWAYS OF HUMAN LABOR
combine to weaken membranes during late gestation [45] . Recent studies from our laboratory and others have shown that SC fetal membranes exhibit characteristics of apoptosis and remodeling that are similar to those observed in labored fetal membranes, suggesting that this site most likely represents the site most likely to rupture [45] . The prelabor SCS is an area of the fetal membranes that is morphologically and biochemically different from other aspects of fetal membranes. We and others have shown that this area is associated with increased connective tissue thickness, fewer nuclei in the amnion epithelium layer and the absence of decidua [24, [46] [47] [48] , and increased apoptosis [24, 46, 47, 49] , ECM remodeling [50] , NFKB signaling [22] , and acetylated FOXO1 expression [23] .
In this study we have demonstrated that when compared to distal fetal membranes, SC fetal membranes have decreased gene and protein expression of SIRT2. There was, however, no difference in the expression of SIRT1 between the two sites. Unlike SIRT1, very little is known about the role and regulation of SIRT2. However, the available data do suggest that it enhances the ability of cells to cope with oxidative stress [51] . Additionally, SIRT2 functions as a tubulin deacetylase that enhances microtubule stability [52] . Microtubules, which consist of polymers of a-and b-tubulin dimers, are major components of the cytoskeleton. They play important roles in many cellular processes including cell division, cell migration, and cellular signaling. There are changes in the structure, organization, and tensile strength of prelabor fetal membrane overlying the cervix [45] , and this impairment in structural integrity of SC fetal membranes most likely underlies membrane rupture. Thus, decreased SIRT2 at SC fetal membranes may lead to less tubulin deacetylation, which would subsequently lead to weakening of the cytoskeleton. Both mRNA and protein levels of SIRT1 were shown to decrease significantly in placenta and fetal membranes after spontaneous-onset labor. In contrast, there was no significant difference in the expression of SIRT2 in placenta and fetal membranes obtained from women after spontaneous labor and delivery to that obtained from women at cesarean section before labor onset. Given that a physiological function of SIRT1 is anti-inflammatory [3] , the down-regulation of SIRT1 protein expression in human gestational tissues with labor onset reported in the present study may contribute to uterine contractions associated with labor. In keeping with this, in this study we show that known mediators of preterm labor, LPS and proinflammatory cytokines [53, 54] , decrease SIRT1 in human placenta.
Human labor is considered an inflammatory state, and pathological and epidemiological evidence suggests that proinflammatory cytokines and prostaglandins play a central role in infection-induced preterm labor and delivery. Experimental data from cell culture, animal models, and tissue studies have provided evidence that prostaglandins and proinflammatory cytokines accumulate in the amniotic fluid and intrauterine tissues of women at the time of labor at term, and they are elevated even further in infection-associated preterm labor [6, 9, 55, 56] . Prostaglandins, especially PGE 2 and PGF 2a , derived by a complex cascade of chemical reactions involving COX isozymes, are recognized as proximal factors that promote myometrial contractility and cervical dilatation. In addition to prostaglandins, proinflammatory cytokines (e.g., TNF, IL1B, and IL6) are localized to intrauterine tissues and are principal mediators of many of the processes involved in parturition. These proinflammatory cytokines act locally on intrauterine cells to 1) further induce phospholipid metabolizing enzymes and stimulate the ongoing release of prostaglandins and 2) activate various ECM remodeling enzymes to stimulate the processes of human labor. In this study, activation of SIRT1 by resveratrol and SRT1720 and knockdown of SIRT1 by siRNA demonstrated an important role in regulation of prolabor mediators.
Resveratrol, a polyphenol phytochemical, has been identified in almost 70 species of plants, red grapes, peanuts, vegetables, berries, beverages, and herbal medicines [57] [58] [59] . It possesses anti-inflammatory, immunomodulatory, antioxidant, cardioprotective, and chemopreventive effects [60] . The data presented in this study demonstrate that in human gestational tissues, LPS-induced increases in the release of proinflammatory cytokines and prostaglandins are relieved by resveratrol cotreatment. Furthermore, knockdown of SIRT1 by siRNA alleviated the anti-inflammatory actions of resveratrol in primary amnion cells. The specificity of SIRT1 in the regulation of proinflammatory cytokines and prostaglandins was also demonstrated by using the synthetic SIRT1 activator SRT1720. In particular, we demonstrated that SRT1720 decreases LPS-induced cytokine and PTGS2 gene expression in human villous placental tissue. This was associated with decreased cytokine and prostaglandin release from human placenta. Collectively, these data demonstrate that SIRT1 is a regulator of proinflammatory cytokines and prostaglandins in human gestational tissues. Of note, pregnancy is associated with very high levels of circulating steroids, and steroid withdrawal is associated with the up-regulation of inflammatory cytokines [61] . However, in our explant cultures, we did not examine the potential affect of steroid withdrawal on any of the parameters examined. This may have potentially confounding issue with regard to interpretation of these results.
SIRT1 modulates gene expression in target tissues by regulating transcriptional coregulators or by directly interacting with transcription factors. NFKB is known to be regulated by acetylation both in vitro and in vivo [19, 62] , and SIRT1 has been shown to physically interact with RELA, the p65 subunit of NFKB, and inhibits transcription by deacetylating RELA at lysine 310 [15, 18] , and deacetylation attenuates NFKB transcriptional activation. Our previous studies support a role for NFKB signaling in the processes of human labor whereby RELA activity is increased in postlabor fetal membranes [12] and NFKB regulates prolabor mediators in human gestational tissues [12, 13, 63] . In nongestational tissues, reduction in SIRT1 activity causes hyperacetylation of NFKB, leading to enhancement of its activity as well as increased histone acetylation at the NFKB binding site on the MMP9 promoter [17] ; SIRT1 overexpression prevents cytokine-mediated cytotoxicity, nitric oxide (NO) production, and inducible NO synthase (iNOS) expression via deacetylation of RELA [16] ; exposure to cigarette smoke decreases in SIRT1 and SIRT2 levels and/or activity, with a concomitant increase in NFKBdependent proinflammatory mediator release [19] ; LPS significantly decreases SIRT1 activation with a concomitant increase in RELA acetylation and TNF production [20] ; and mutation or knockdown of SIRT1 increases acetylation of RELA and IL8 release, whereas overexpression of SIRT1 decreased IL8 release in response to cigarette smoke extract in MonoMac6 cells [18] . Collectively, these data suggest that SIRT1 plays a pivotal role in regulation of NFKB-dependent proinflammatory mediator expression. Many studies in nongestational tissues have shown that many of the actions of resveratrol are via modulation of NFKB [38] [39] [40] [41] [42] [43] [44] . However, in this study, short, intermediate, and prolonged resveratrol treatment did not attenuate basal or LPS-induced NFKBIA degradation or NFKB activation, mRNA, and/or nuclear protein expression. Collectively, these data suggest that SIRT1 does not play a role in regulation of NFKB in human gestational tissues. Sirtuins have also been shown to regulate the transcriptional activity of other transcription factors. SIRT1 deacetylates and represses the activity of FOXO protein [64] , whereas it activates anti-inflammatory transcription factors, such as PPAR [21] . Previously, studies have demonstrated the importance of these two transcription factors in the processes of human labor and delivery [10] [11] [12] 14] ; activation of PPARG leads to antiinflammatory actions in human gestational tissues [65] [66] [67] . Future studies determining the effect relationship between SIRT1 and other transcriptions factors in human gestational tissues are warranted.
Preterm labor and its consequences are the major contributors to perinatal morbidity and mortality worldwide. The terminal pathways of spontaneous preterm and term labor are the same: increased myometrial contractility and cervical ripening, and fetal membrane rupture. A critical role for cytokines, prostaglandins, and ECM remodeling enzymes in these processes has been demonstrated. Term labor results from physiologic activation of this pathway; preterm labor occurs after pathologic activation, with intrauterine infection and/or inflammation the most firmly established trigger. To our knowledge, this is the first study to demonstrate a role for SIRT1 as a key regulator of human parturition. Specifically, human term spontaneous labor is associated with decreased SIRT1 levels in human gestational tissues. We also show that SIRT1 is anti-inflammatory; it is down-regulated by prolabor cytokines and bacterial endotoxin, and prolabor mediators are down-regulated by SIRT1 activation and up-regulated by SIRT1 inhibition. Collectively, these data suggest that SIRT1 may be involved in the maintenance of pregnancy and parturition and, as such, presents an attractive therapeutic target for preterm labor. Indeed, previous studies have shown SIRT1 to be essential for normal embryogenesis; Sirt1 knockout mice have a severe phenotype, with a high degree of embryonic and postnatal lethality [68, 69] . Future studies defining the signaling pathways upstream and downstream of SIRT1 and characterizing their roles in human pregnancy are warranted. An understanding of SIRT1 and its biology in the processes of human labor will provide new opportunities for developing more effective therapeutic approaches to treat preterm labor.
